| Catalog Number | 67873-1-Ig |
| Synonyms | MAP2K1, MEK1, MAPKK 1, MAP2K 1, EC:2.7.12.2 |
| Host | Mouse |
| Reactivity | Human, mouse, rat |
| Reactivity | human, mouse, rat |
| Form | Liquid |
| Formulation | PBS, Azide, Glycerol |
| Applications | WB, FC (Intra), ELISA |
| Applications | WB, ELISA, FC (Intra) |
| Host / Isotype | Mouse / IgG1 |
| Tested Applications — Positive WB detected in | NIH/3T3 cells, A431 cells, Calyculin A treated HeLa cells, Nocodazole treated A431 cells, Calyculin A treated NIH/3T3 cells, Calyculin A treated HSC-T6 cells |
| Tested Applications — Positive FC (Intra) detected in | Calyculin A treated HeLa cells |
| Recommended Dilutions — Western Blot (WB) | WB : 1:2000-1:10000 |
| Recommended Dilutions — Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.13 ug per 10^6 cells in a 100 µl suspension |
| Positive WB detected in | NIH/3T3 cells, A431 cells, Calyculin A treated HeLa cells, Nocodazole treated A431 cells, Calyculin A treated NIH/3T3 cells, Calyculin A treated HSC-T6 cells |
| Positive FC (Intra) detected in | Calyculin A treated HeLa cells |
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.13 ug per 10^6 cells in a 100 µl suspension |
| Tested Reactivity | Human, mouse, rat |
| Cited Reactivity | mouse, rat |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen | Peptide Predict reactive species |
| Full Name | mitogen-activated protein kinase kinase 1 |
| Calculated Molecular Weight | 43 kDa |
| Observed Molecular Weight | 40-50 kDa |
| GenBank Accession Number | BC139729 |
| Gene Symbol | MEK1 |
| Gene ID (NCBI) | 5604 |
| ENSEMBL Gene ID | ENSG00000169032 |
| RRID | AB_2918631 |
| Conjugate | Unconjugated |
| Purification Method | Protein G purification |
| UNIPROT ID | Q02750 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20 o C storage. 20ul sizes contain 0.1% BSA. |
| WB protocol for Phospho-MEK1 (Thr292) antibody 67873-1-Ig | Download protocol |
| mouse | WB NPJ Breast Cancer Cancer-associated adipomes promote invadopodia formation and enhance metastatic potential in triple-negative breast cancer. Authors - Hariprasad Thangavel View Article |
| rat | WB J Ethnopharmacol Jia-Wei-Si-Miao-Yong-An Fang stimulates the healing of acute radiation-induced cutaneous wounds through MAPK/ERK pathway Authors - Yin Wang View Article |
| Citations | 4 |
| Dilutions | WB : 1:2000-1:10000 FC (INTRA) : 0.13 ug per 10^6 cells in a 100 µl suspension |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Clone Number | 2D7A8 |
| Conjugation | Unconjugated |
MAP2K1 encodes MAPK1, also known as MEK1. MEK1 variants can enhance MEK1 expression and ERK1 phosphorylation that together lead to continuous activation of MEK/ERK signaling pathway. MEK1 bind directly to ERK2 through a region in the N terminus of MEK. In addition, a proline-rich (PR) regulatory sequence in MEK is also involved in MEK-ERK association and signal propagation. The coupling between MEK1 and ERK2 is enhanced through phosphorylation on S298 in the MEK1 PR region, whereas phosphorylation on MEK1 T292 releases the complex. MEK1 T292 is a substrate of ERK2, but the site is also phosphorylated at a basal level when ERK2 is inhibited, suggesting several regulators of this site . Although the S298 site in MEK2 has been conserved, it lacks the T292 phosphorylation site, and it is not a substrate of PAK1. (PMID: 31972311, PMID: 17928366, PMID: 22177953) Protocols Product Specific Protocols WB protocol for Phospho-MEK1 (Thr292) antibody 67873-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols
Publications
Product Documents